Greenwich LifeSciences (GLSI) Interest Expenses (2019 - 2025)

Greenwich LifeSciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $9.3 million for Q4 2025.

• Quarterly Interest Expenses rose 39.71% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (up 39.71% YoY) and the FY2025 annual result came in at $9.3 million, up 39.71% from the prior year.
• Interest Expenses was $9.3 million for Q4 2025 at Greenwich LifeSciences, up from $6.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $9.3 million in Q4 2025 and bottomed at $1.5 million in Q4 2021.
• A 5-year average of $3.8 million and a median of $2.6 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses surged 107.18% — and 2025, when it soared 39.71%.
• Greenwich LifeSciences' Interest Expenses stood at $1.5 million in 2021, then jumped by 107.18% to $3.1 million in 2022, then soared by 43.6% to $4.5 million in 2023, then soared by 47.36% to $6.6 million in 2024, then surged by 39.71% to $9.3 million in 2025.
• Business Quant data shows GLSI's Interest Expenses at $9.3 million in Q4 2025, $6.6 million in Q4 2024, and $4.5 million in Q4 2023.